Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor.
Wenjing XuChangting CuiChunmei CuiZhenzhen ChenHaizeng ZhangQinghua CuiGuoheng XuJianglin FanYu HanLiangjie TangGiovanni TargherChristopher D ByrneMing-Hua ZhengLiming YangJun CaiBin GengPublished in: Hepatology (Baltimore, Md.) (2022)
S and FXR may be amenable to therapeutic drug treatment in NAFLD.